Search Orphan Drug Designations and Approvals
-
Generic Name: | (3S)-(+)-(5-chloro-2-methoxyphenyl)-1,3-dihydro-3-fluoro-6-(trifluoromethyl)-2H-indol-2-one |
---|---|
Date Designated: | 12/09/2015 |
Orphan Designation: | Treatment of Fragile X Syndrome. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Centre National de la Recherche Scientifique (CNRS) 3 Rue Michel-Ange Paris France The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-